Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Huang, Y. B. Chen, P. Xu (Suzhou, China). The expression and clinical significance of PD-L1⁺CD68⁺ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer. Eur Respir J 2011; 38: Suppl. 55, 2796

Member's Comments

No comment yet.

Related content which might interest you: Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 EpCAM-positive circulating cells in lung cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Changes and significance of CD4+CD25+ T cells in patients with lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Distribution of peripheral blood cytotoxic T lymphocytes in different histological types of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 308s Year: 2005 Alteration in subpopulations of peripheral T lymphocytes in squamous cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 91s Year: 2005 Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Influence of tumour cell lysate on state of lymphocytes‘ activation after DCs stimulation in lung cancer Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004 Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Programmed death-1 T cells in lung cancer- a comparison of BALF cells from affected lung to healthy lung and peripheral blood Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Prognostic significance of CD-3 T-cells and NK cells in surgically treated non-small cell lung carcinomas Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 529s Year: 2004 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004